Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where authors phrase all words ' BERGER U' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 75 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Harbeck, N; Alt, U; Berger, U; Kruger, A; Thomssen, C; Janicke, F; Hofler, H; Kates, RE; Schmitt, M
      Prognostic impact of proteolytic factors (Urokinase-Type plasminogen activator, plasminogen activator inhibitor 1, and cathepsins B, D, and L) in primary breast cancer reflects effects of adjuvant systemic therapy

      CLINICAL CANCER RESEARCH
    2. Schmalfeldt, B; Prechtel, D; Harting, K; Spathe, K; Rutke, S; Konik, E; Fridman, R; Berger, U; Schmitt, M; Kuhn, W; Lengyel, E
      Increased expression of matrix metalloproteinases (MMP)-2, MMP-9, and the urokinase-type plasminogen activator is associated with progression from benign to advanced ovarian cancer

      CLINICAL CANCER RESEARCH
    3. Sendler, A; Gilbertz, KP; Becker, I; Mueller, J; Berger, U; Fink, U; van Beuningen, D; Siewert, JR
      Proliferation kinetics and prognosis in gastric cancer after resection

      EUROPEAN JOURNAL OF CANCER
    4. Berger, U; Oehme, M; Girardin, L
      Quantification of derivatives of bisphenol A diglycidyl ether (BADGE) and novolac glycidyl ether (NOGE) migrated from can coatings into tuna by HPLC/fluorescence and MS detection

      FRESENIUS JOURNAL OF ANALYTICAL CHEMISTRY
    5. Gaebler, C; Berger, U; Schandelmaier, P; Greitbauer, M; Schauwecker, HH; Applegate, B; Zych, G; Vecsei, V
      Rates and odds ratios for complications in closed and open tibial fractures treated with unreamed, small diameter tibial nails: A multicenter analysis of 467 cases

      JOURNAL OF ORTHOPAEDIC TRAUMA
    6. Hochhaus, A; Lahaye, T; Kreil, S; Berger, U; Metzgeroth, G; Hehlmann, R
      Selective inhibition of tyrosine kinases - a new therapeutic principle in oncology

      ONKOLOGIE
    7. Braumann, O; Greuel, HW; Heitkotter, B; Schneider, HJ; Scholle, W; Schoneberg, U; Berger, U
      Bright steel - tightest tolerances and host surfaces for demanding final products

      STAHL UND EISEN
    8. Berger, U; Niggl, KH; Reus, B
      Theoretical computer science - Logic, semantics and theory of programming - Preface

      THEORETICAL COMPUTER SCIENCE
    9. Lengyel, E; Schmalfeldt, B; Konik, E; Spathe, K; Harting, K; Fenn, A; Berger, U; Fridman, R; Schmitt, M; Prechtel, D; Kuhn, W
      Expression of latent matrix metalloproteinase 9 (MMP-9) predicts survival in advanced ovarian cancer

      GYNECOLOGIC ONCOLOGY
    10. Hochhaus, A; Kreil, S; Corbin, A; La Rosee, P; Lahaye, T; Berger, U; Cross, NCP; Linkesch, W; Druker, BJ; Hehlmann, R
      Roots of clinical resistance to STI-571 cancer therapy

      SCIENCE
    11. Prechtel, D; Harbeck, N; Berger, U; Hofler, H; Werenskiold, AK
      Clinical relevance of T1-S, an oncogene-inducible, secreted glycoprotein of the immunoglobulin superfamily, in node-negative breast cancer

      LABORATORY INVESTIGATION
    12. de la Fuente, J; Merx, K; Steer, EJ; Muller, M; Szydlo, RM; Maywald, O; Berger, U; Hehlmann, R; Goldman, JM; Cross, NCP; Melo, JV; Hochhaus, A
      ABL-BCR expression does not correlate with deletions on the derivative chromosome 9 or survival in chronic myeloid leukemia

      BLOOD
    13. Ulm, K; Nekarda, H; Gerein, P; Berger, U
      Statistical methods to identify prognostic factors

      HANDBOOK OF STATISTICS IN CLINICAL ONCOLOGY
    14. Berger, U; Oehme, M
      Identification of derivatives of bisphenol A diglycidyl ether and novolac glycidyl ether in can coatings by liquid chromatography/ion trap mass spectrometry

      JOURNAL OF AOAC INTERNATIONAL
    15. Hehlmann, R; Hochhaus, A; Berger, U; Reiter, A
      Current trends in the management of chronic myelogenous leukemia

      ANNALS OF HEMATOLOGY
    16. Lengfelder, E; Berger, U; Hehlmann, R
      Interferon alpha in the treatment of polycythemia vera

      ANNALS OF HEMATOLOGY
    17. Hochhaus, A; Weisser, A; La Rosee, P; Emig, M; Muller, MC; Saussele, S; Reiter, A; Kuhn, C; Berger, U; Hehlmann, R; Cross, NCP
      Detection and quantification of residual disease in chronic myelogenous leukemia

      LEUKEMIA
    18. Harbeck, N; Alt, U; Berger, U; Kates, R; Kruger, A; Thomssen, C; Janicke, F; Graeff, H; Schmitt, M
      Long-term follow-up confirms prognostic impact of PAI-1 and cathepsin D and L in primary breast cancer

      INTERNATIONAL JOURNAL OF BIOLOGICAL MARKERS
    19. Saint-Paul, U; Zuanon, J; Correa, MAV; Garcia, M; Fabre, NN; Berger, U; Junk, WJ
      Fish communities in central Amazonian white- and blackwater floodplains

      ENVIRONMENTAL BIOLOGY OF FISHES
    20. Nettelbeck, HJ; Berger, U
      The cold rolling committee and technical developments of cold rolling and surface treatment (vol 120, pg 43, 2000)

      STAHL UND EISEN
    21. Nettelbeck, HJ; Berger, U
      The cold rolling committee and technical developments of cold rolling and surface treatment

      STAHL UND EISEN
    22. Berger, U; Hildenbrandt, H
      A new approach to spatially explicit modelling of forest dynamics: Spacing, ageing and neighbourhood competition of mangrove trees

      ECOLOGICAL MODELLING
    23. Heyer, J; Berger, U
      Methane emission from the coastal area in the southern Baltic Sea

      ESTUARINE COASTAL AND SHELF SCIENCE
    24. Mummendey, A; Otten, S; Berger, U; Kessler, T
      Positive-negative asymmetry in social discrimination: Valence of evaluation and salience of categorization

      PERSONALITY AND SOCIAL PSYCHOLOGY BULLETIN
    25. Hochhaus, A; Reiter, A; Saussele, S; Reichert, A; Emig, M; Kaeda, J; Schultheis, B; Berger, U; Shepherd, PCA; Allan, NC; Hehlmann, R; Goldman, JM; Cross, NCP
      Molecular heterogeneity in complete cytogenetic responders after interferon-alpha therapy for chronic myelogenous leukemia: low levels of minimal residual disease are associated with continuing remission

      BLOOD
    26. Emig, M; Saussele, S; Wittor, H; Weisser, A; Reiter, A; Willer, A; Berger, U; Hehlmann, R; Cross, NCP; Hochhaus, A
      Accurate and rapid analysis of residual disease in patients with CML usingspecific fluorescent hybridization probes for real time quantitative RT-PCR

      LEUKEMIA
    27. Kropfl, A; Davies, J; Berger, U; Hertz, H; Schlag, G
      Intramedullary pressure and bone marrow fat extravasation in reamed and unreamed femoral nailing

      JOURNAL OF ORTHOPAEDIC RESEARCH
    28. Berger, U; Wagner, G; Wolff, WF
      Virtual biologists observe virtual grasshoppers: an assessment of different mobility parameters for the analysis of movement patterns

      ECOLOGICAL MODELLING
    29. Harbeck, N; Thomssen, C; Berger, U; Ulm, K; Kates, RE; Hofler, H; Janicke, F; Graeff, H; Schmitt, M
      Invasion marker PAI-1 remains a strong prognostic factor after long-term follow-up both for primary breast cancer and following first relapse

      BREAST CANCER RESEARCH AND TREATMENT
    30. Mansi, JL; Gogas, H; Bliss, JM; Gazet, JC; Berger, U; Coombes, RC
      Outcome of primary-breast-cancer patients with micrometastases: a long-term follow-up study

      LANCET
    31. Kremp, C; Berger, U; Hoffmann, P; Keuer, D; Sonnemann, GR
      Seasonal variation of middle latitudes wind fields of the mesopause region- a comparison between observation and model calculation

      GEOPHYSICAL RESEARCH LETTERS
    32. Berger, U
      Case report from veterinary behaviour medicine

      SCHWEIZER ARCHIV FUR TIERHEILKUNDE
    33. Berger, U; Oehme, M; Kuhn, F
      Quantitative determination and structure elucidation of type A- and B-trichothecenes by HPLC/ion trap multiple mass spectrometry

      JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY
    34. Schmalfeldt, B; Kuhn, W; Harbeck, N; Spathe, K; Dettmar, P; Berger, U; Schmitt, M; Graeff, H
      Indicators of proliferation and invasion in ovarian tumors of low malignant potential

      GEBURTSHILFE UND FRAUENHEILKUNDE
    35. Berger, U; Kolliker, S; Oehme, M
      Structure elucidation and quantification by HPLC ion-trap multiple mass spectrometry

      CHIMIA
    36. Harbeck, N; Dettmar, P; Thomssen, C; Berger, U; Ulm, K; Kates, R; Hofler, H; Janicke, F; Graeff, H; Schmitt, M
      Risk group discrimination in node-negative breast cancer using invasion and proliferation markers: 6-year median follow up

      BRITISH JOURNAL OF CANCER
    37. Kuhn, W; Schmalfeldt, B; Reuning, U; Pache, L; Berger, U; Ulm, K; Harbeck, N; Spathe, K; Dettmar, P; Hofler, H; Janicke, F; Schmitt, M; Graeff, H
      Prognostic significance of urokinase (uPA) and its inhibitor PAI-1 for survival in advanced ovarian carcinoma stage FIGO IIIc

      BRITISH JOURNAL OF CANCER
    38. Hehlmann, R; Hochhaus, A; Kolb, HJ; Hasford, J; Gratwohl, A; Heimpel, H; Siegert, W; Finke, J; Ehninger, G; Holler, E; Berger, U; Pfirrmann, M; Muth, A; Zander, A; Fauser, AA; Heyll, A; Nerl, C; Hossfeld, DK; Loffler, H; Pralle, H; Queisser, W; Tobler, A
      Interferon-alpha before allogeneic bone marrow transplantation in chronic myelogenous leukemia does not affect outcome adversely, provided it is discontinued at least 90 days before the procedure

      BLOOD
    39. Berger, U; von Zahn, U
      The two-level structure of the mesopause: A model study

      JOURNAL OF GEOPHYSICAL RESEARCH-ATMOSPHERES
    40. SONNEMANN G; KREMP C; EBEL A; BERGER U
      A 3-DIMENSIONAL DYNAMIC-MODEL OF THE MINOR CONSTITUENTS OF THE MESOSPHERE

      Atmospheric environment
    41. JANICKE F; THOMSSEN C; HARBECK N; PRECHTL A; BERGER U; ULM K; DETTMAR P; PACHE L; SCHMITT M; GRAEFF H
      TUMORBIOLOGICAL FACTORS (UPA, PAI-1) AS SELECTION CRITERIA FOR ADJUVANT CHEMOTHERAPY IN AXILLARY NODE-NEGATIVE BREAST-CANCER PATIENTS

      European journal of cancer
    42. BUCKMANN O; KROMKER M; BERGER U
      AN APPLICATION PLATFORM FOR THE DEVELOPMENT AND EXPERIMENTAL VALIDATION OF MOBILE ROBOTS FOR HEALTH-CARE PURPOSES

      Journal of intelligent & robotic systems
    43. HORAK F; TOTH J; HIRSCHWEHR R; MARKS B; STUBNER UP; JAGER S; BERGER U; SCHLEINZER K; GUNCZLER P
      EFFECT OF CONTINUOUS ALLERGEN CHALLENGE ON CLINICAL SYMPTOMS AND MEDIATOR RELEASE IN DUST-MITE-ALLERGIC PATIENTS

      Allergy
    44. HIRSCHWEHR R; HEPPNER C; SPITZAUER S; SPERR WR; VALENT P; BERGER U; HORAK F; JAGER S; KRAFT D; VALENTA R
      IDENTIFICATION OF COMMON ALLERGENIC STRUCTURES IN MUGWORT AND RAGWEEDPOLLEN

      Journal of allergy and clinical immunology
    45. TEMMEL AFP; TOTH J; MARKS B; JAGER S; BERGER U; REISER K; HORAK F
      RHINORESISTOMETRY VERSUS RHINOMANOMETRY - AN EVALUATION

      Wiener Klinische Wochenschrift
    46. HEHLMANN R; HOCHHAUS A; BERGER U; MUTH A; KOLB HJ; PFIRRMANN M; HASFORD J
      SURVIVAL AFTER ALLOGENOUS BONE-MARROW TRANSPLANTATION IN PATIENTS WITH CHRONIC MYELOID-LEUKEMIA (CML) IS NOT INFLUENCED BY PRETRANSPLANT INTERFERON-ALPHA THERAPY

      British Journal of Haematology
    47. GUNSHIN H; GUNSHIN Y; BERGER U; NUSSBERGER S; MACKENZIE B; GOLLAN JL; HEDIGER MA
      EXPRESSION CLONING OF AN IRON TRANSPORTER (IDCT1) IN RAT DUODENUM

      The FASEB journal
    48. SAMIETZ J; BERGER U
      EVALUATION OF MOVEMENT PARAMETERS IN INSECTS - BIAS AND ROBUSTNESS WITH REGARD TO RESIGHT NUMBERS

      Oecologia
    49. HOCHHAUS A; BERGER U; ANSARI H; HASFORD J; HEHLMANN R
      PROSPECTIVE COMPARATIVE-ANALYSIS OF ADVERSE-EFFECTS DURING THE TREATMENT OF PATIENTS WITH CHRONIC MYELOGENOUS LEUKEMIA IN CHRONIC PHASE WITH INTERFERON-ALPHA, BUSULFAN AND HYDROXYUREA

      Blood
    50. HEHLMANN R; KOLB HJ; BERGER U; MUTH A; HOCHHAUS A; ANSARI H
      INFLUENCE OF PRETRANSPLANT TREATMENT ON SURVIVAL AFTER ALLOGENEOUS BONE-MARROW TRANSPLANTATION IN CML

      Blood
    51. HOCHHAUS A; HEHLMANN R; BARTRAM CR; HEIMPEL H; REITER A; BERGER U; ANSARI H; SKLADNY H; HEINZE B; HOSSFELD DK
      RANDOMIZED COMPARISON OF INTERFERON-ALPHA VS CHEMOTHERAPY IN PATIENTSWITH PHILADELPHIA-NEGATIVE CHRONIC MYELOGENOUS LEUKEMIA (CML)

      Blood
    52. KROPFL A; BERGER U; NEUREITER H; HERTZ H; SCHLAG G
      INTRAMEDULLARY PRESSURE AND BONE-MARROW FAT INTRAVASATION IN UNREAMEDFEMORAL NAILING

      The journal of trauma, injury, infection, and critical care
    53. BERGER U; SCHNICK W
      BA2NA(CN2)(CN)(3), A NOVEL CYANAMIDE CYAN IDE WITH INTERPENETRATING SUBSTRUCTURES

      Zeitschrift fur Naturforschung. B, A journal of chemical sciences
    54. HOSS R; KONIG O; KRAMERHOSS V; BERGER U; ROGIN P; HULLIGER J
      CRYSTALLIZATION OF SUPRAMOLECULAR MATERIALS - PERHYDROTRIPHENYLENE (PHTP) INCLUSION-COMPOUNDS WITH NONLINEAR-OPTICAL PROPERTIES

      Angewandte Chemie, International Edition in English
    55. HEHLMANN R; HEIMPEL H; HOSSFELD DK; HASFORD J; KOLB HJ; LOFFLER H; PRALLE H; QUEISSER W; HOCHHAUS A; TICHELLI A; FETT W; SCHMITZ N; REITER A; GRIESSHAMMER M; PFEIFER W; BAUMLER M; KAMP T; TOBLER A; EIMERMACHER H; KUSE R; BERGER U; ANSARI H
      RANDOMIZED STUDY OF THE COMBINATION OF HYDROXYUREA AND INTERFERON-ALPHA VERSUS HYDROXYUREA MONOTHERAPY DURING THE CHRONIC PHASE OR CHRONIC MYELOGENOUS LEUKEMIA (CML-STUDY-II)

      Bone marrow transplantation
    56. WILHELM P; BOSS C; PFAMMATTER M; THOMMEN M; PLOOM T; SCHAUDER S; BERGER U; VANHELMONT F; FORTSCH M; HAUSER J; BURGI HB
      6-DICHLORO-1,3,5-TRIAZIN-2-YLETHYNYL)DIMETHYLAMINE

      Acta crystallographica. Section C, Crystal structure communications
    57. HORAK F; BERGER U; MENAPACE R; SCHUSTER N
      QUANTIFICATION OF CONJUNCTIVAL VASCULAR REACTION BY DIGITAL IMAGING

      Journal of allergy and clinical immunology
    58. BERGER U
      THE MAP-OF-METLATOYUCA - A MEXICAN MANUSCRIPT IN THE COLLECTION OF THE BRITISH-MUSEUM

      Cartographic Journal
    59. HOCHHAUS A; REITER A; SKLADNY H; MELO JV; SICK C; BERGER U; GUO JQ; ARLINGHAUS RB; HEHLMANN R; GOLDMAN JM; CROSS NCP
      A NOVEL BCR-ABL, FUSION GENE (E6A2) IN A PATIENT WITH PHILADELPHIA CHROMOSOME-NEGATIVE CHRONIC MYELOGENOUS LEUKEMIA

      Blood
    60. LENGFELDER E; HOCHHAUS A; BERGER U; QUEISSER W; ANSARI H; HEHLMANN R
      CLINICAL COURSE AND DIAGNOSTIC-CRITERIA IN PATIENTS WITH EARLY STAGESOF ESSENTIAL THROMBOCYTHEMIA

      Blood
    61. HORAK F; JAGER S; TOTH J; BERGER U
      EFFICACY AND TOLERABILITY OF ASTEMIZOLE-D AND LORATADINE-D DURING PROLONGED, CONTROLLED ALLERGEN CHALLENGE IN THE VIENNA CHALLENGE CHAMBER

      Arzneimittel-Forschung
    62. BERGER U; SCHULTZCOULON V; SCHNICK W
      CA2SR[WN4], THE FIRST MIXED ALKALINE-EART H NITRIDOTUNGSTATE

      Zeitschrift fur Naturforschung. B, A journal of chemical sciences
    63. ZIMNIK W; DECHENE W; SCHWICH V; STECK K; WOLPERT W; BERGER U
      ROLLING TECHNOLOGY AND COATING OF AUTOBOD Y SHEET

      Stahl und Eisen
    64. BERGER U; MILIUS W; SCHNICK W
      BA-2(CN2)(CN)(2) AND SR-2(CN2)(CN)(2) - T HE FIRST MIXED CYANAMIDE CYANIDES

      Zeitschrift fur anorganische und allgemeine Chemie
    65. BEERHUES L; BERGER U
      DIFFERENTIAL ACCUMULATION OF XANTHONES IN METHYL-JASMONATE-TREATED AND YEAST-EXTRACT-TREATED CELL-CULTURES OF CENTAURIUM-ERYTHRAEA AND CENTAURIUM-LITTORALE

      Planta
    66. HORAK FF; JAGER S; NIRNBERGER G; BERGER U; ANDRESEN I; VIX JM; REHN D
      DOSE-RELATED CONTROL OF ALLERGIC RHINITIS SYMPTOMS BY A H1-RECEPTOR ANTAGONIST - FINDING THE PROPER DOSIS OF DIMETHINDENE MALEATE IN PATIENTS WITH ALLERGIC RHINITIS

      International archives of allergy and immunology
    67. BERGER U; SCHNICK W
      SYNTHESES, CRYSTAL-STRUCTURES, AND VIBRATIONAL SPECTROSCOPIC PROPERTIES OF MGCN2, SRCN2, AND BACN2

      Journal of alloys and compounds
    68. HORAK F; JAGER S; TOTH J; BERGER U; NIRNBERGER E
      AZELASTINE IN POLLEN-INDUCED ALLERGIC RHINITIS - A PHARMACODYNAMIC STUDY OF ONSET OF ACTION AND EFFICACY

      Drug investigation
    69. HORAK F; JAGER S; BERGER U; TOTH J; NIRNBERGER G; KYREIN HJ; REHN D; VIX JH
      CONTROLLED EXPOSURE TO MITE ALLERGEN FOR A DOSE-FINDING OF DIMETHINDENE MALEATE (DMM)

      Agents and actions
    70. BEERHUES L; BERGER U
      XANTHONES IN CELL-SUSPENSION CULTURES OF 2 CENTAURIUM SPECIES

      Phytochemistry
    71. BERGER U; DAMERIS M
      COOLING OF THE UPPER-ATMOSPHERE DUE TO CO2 INCREASES - A MODEL STUDY

      Annales geophysicae
    72. COYLE JT; PUTTFARKEN P; BERGER U; MEYERHOFF J; PASSANI L
      N-ACETYL GLUTAMATE - DUAL ROLE AS SYNAPTIC GLUTAMATE PRECURSOR AND NMDA ANTAGONIST

      Neuropsychopharmacology
    73. BERGER U
      DRIVE AND CONTROL ENGINEERING IN COLD MIL LS

      Stahl und Eisen
    74. HORAK F; TOTH J; JAGER S; BERGER U
      EFFECTS OF H-1-RECEPTOR ANTAGONISTS ON NASAL OBSTRUCTION IN ATOPIC PATIENTS

      Allergy
    75. HORAK F; JAGER S; NIRNBERGER G; BERGER U; ANDRESEN I; VIX JM; REHN D
      PHARMACODYNAMIC DOSE-FINDING OF DIMETINDENE IN A SUSTAINED-RELEASE FORMULATION

      Arzneimittel-Forschung


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 21/10/20 alle ore 03:56:44